New cream shows promise for chronic skin condition
Disease control
Not yet recruiting
This study tests a cream called delgocitinib for people with lichen sclerosus, a chronic skin condition that causes itching, pain, and scarring. About 652 adults will apply the cream twice daily for up to 60 weeks. The goal is to see if it improves skin symptoms and reduces pain …
Phase: PHASE3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated May 05, 2026 11:55 UTC